Work

E3A06: Randomized phase III trial of lenalidomide versus observation alone in patients with asymptomatic high-risk smoldering multiple myeloma.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.8001

Authors: Sagar Lonial, Susanna J. Jacobus, Matthias Weiss, Shaji Kumar, Robert Z. Orlowski, Jonathan L. Kaufman, Abdulraheem Yacoub, Francis Buadi, Timothy E. O'Brien, Jeffrey Matous, Daniel M. Anderson, Robert Emmons, Madhav V. Dhodapkar, Lynne I. Wagner, S. Vincent Rajkumar

Institutions: Winship Cancer Institute, Dana-Farber Cancer Institute, ThedaCare, Mayo Clinic, The University of Texas MD Anderson Cancer Center, The University of Kansas Cancer Center, MetroHealth, MetroHealth Medical Center, Case Western Reserve University, Colorado Blood Cancer Institute, Regions Hospital, Ochsner Medical Center, Yale University, Northwestern University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2954043465

Cites:

Cited by: 28

Related to: 10